RCEL (AVITA Medical) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 24, 2026)


RCEL AVITA Medical Inc RCEL
66 GF Score
Price $3.95
GF Value $10.78
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is AVITA Medical Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

AVITA Medical's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

RCEL vs NNOX, MXCT, SNWV: Margin of Safety % (DCF FCF Based) Comparison

For the Medical Devices subindustry, AVITA Medical's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AVITA Medical Margin of Safety % (DCF FCF Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AVITA Medical's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where AVITA Medical's Margin of Safety % (DCF FCF Based) falls into.


RCEL
66GF Score
AVITA Medical Inc RCEL
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is AVITA Medical (RCEL) Overvalued in 2026?

Based on GuruFocus' analysis, AVITA Medical stock appears to be undervalued. The current stock price of $3.95 is trading 63.4% below its estimated GF Value™ of $10.78. GuruFocus considers AVITA Medical to be Possible Value Trap.

Key valuation signals for RCEL:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: $10.78 vs. price of $3.95 (63.4% below fair value)
  • GF Score™: 66/100 with 6 warning signs

No single metric tells the full story. See the RCEL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AVITA Medical Business Description

Address 28159 Avenue Stanford, Suite 220, Valencia, Santa Clarita, CA, USA, 91355
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
66GF Score

Get the complete analysis for RCEL

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.95
Price
$10.78
GF Value